Sun Yat-sen Memorial Hospital Of Sun Yat-sen University

This study compares a single chemotherapy drug (paclitaxel) against the standard two-drug combo (paclitaxel plus carboplatin) as initial treatment before surgery for advanced ovarian cancer. It includes 60 women whose tumors have a high level of the PARK2 gene, which may make the…

This study tests three different doses of famitinib malate combined with camrelizumab in 120 people with recurrent or metastatic cervical cancer that cannot be cured by standard treatments. The goal is to find the dose that best controls the cancer while reducing serious side eff…

This study tests a combination of three drugs—liposomal irinotecan, sintilimab, and anlotinib—in people with a rare and aggressive ovarian cancer called ovarian clear cell carcinoma that has come back or not gone away after standard treatment. The goal is to see if this drug mix …

This study tests two different drug combinations as a first treatment for people with advanced triple-negative breast cancer that has spread. About 150 participants will receive either sacituzumab govitecan plus toripalimab or toripalimab plus nab-paclitaxel. The goal is to see w…

This study tests a drug called sacituzumab in 22 people with a rare and aggressive ovarian cancer (clear cell carcinoma) whose tumors grew despite immunotherapy. The drug targets a protein on cancer cells to deliver chemotherapy directly, aiming to shrink tumors. Early results su…

This study tests a new approach for people with a hard-to-treat bile duct cancer that has grown into a major liver artery. Normally, this cancer is considered inoperable because removing the artery would cut off blood flow. The idea is to block that artery before surgery, which f…

This study looks at whether removing keloids surgically and then applying a radioactive patch (32P) can prevent them from returning. Keloids are harmless but can be itchy, painful, and affect how people feel about their appearance. The study will follow 401 people for two years t…

This study tests a surgical technique to prevent arm lymphedema (swelling) in women at high risk after breast cancer surgery. The procedure uses a small flap of tissue from the chest wall to help restore normal fluid drainage in the armpit. 100 women with a higher body mass index…

This study compares two ways of giving a large-volume injection under the skin for breast cancer treatment: one using a machine that delivers the medicine at a steady speed, and the other done by a nurse by hand. The goal is to see which method causes less pain. 40 women with HER…

This study will observe 3,000 stroke patients in China who receive clot-busting medicine more than 4.5 hours after their stroke began. The goal is to see if this delayed treatment is safe and helps reduce disability. Participants will be followed for 90 days to measure their reco…

This study looks at whether giving the clot-busting drug tenecteplase more than 4.5 hours after a stroke starts is safe and helpful. Researchers will follow 3,000 adults in China who receive this late treatment in regular hospital care. The goal is to see if patients have less di…

This study looks at whether a color Doppler ultrasound feature called 'twinkling artifact' can make breast tissue marker clips easier to see. About 86 women who had clips placed will have their past ultrasound images reviewed. The goal is to help surgeons find clips more accurate…